Abstract
Background and Aims : Aim of the study was to estimate the impact of CYP2C19 genetic polymorphisms on the antiplatelet response with clopidogrel and their possible relationship between mean platelet volume (MPV) in patients with coronary heart disease (CHD) after percutaneous coronary interventions (PCI).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
